Digital Therapeutics Market 2025 Survey Global industry share, size, trends, and Forecasts By top Players Propeller Health, CANARY HEALTH, Noom, 2Morrow, Livongo Health, Proteus Digital Health

According to a new market research study titled ‘Digital Therapeutics Market to 2025 – Global Analysis and Forecasts by Application and Distribution Channel, the global digital therapeutics market was valued at US$ 1,993.2 Mn in 2017 and is estimated to reach US$ 8,941.1 Mn by 2025. The market is estimated to grow with a CAGR of 20.8% from 2018-2025.The report highlights the trends prevalent in the global digital therapeutics market and the factors driving the market along with those that act as deterrents to its growth.

The report aims to provide an overview of the global remote sensing services market with detailed market segmentation by resolution, platform type, end user, and geography. The global remote sensing services market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the remote sensing services market.

Get Sample PDF OF Report For More Information@ https://www.theinsightpartners.com/sample/TIPHC00002236/?op-sp

Global digital therapeutics market is expected to grow in the coming years, owing to the rising pressure on healthcare providers to reduce healthcare cost in the market. The fiscal pressure and patent cliffs compel healthcare providers to cut on drug prices, encourage the use of generics and scale back the reimbursement. This in turn is gradually reducing the profit margins and annual net sales of the healthcare companies that leads to immediate requirement of a strategic plan so as to cut down on the operational costs.

North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant rate in Asia Pacific (APAC) region during the forecast period. Factors such as, increasing prevalence of the chronic diseases, acceptance of the digital health platforms, developments performed by the market players in the countries such as India, China, Australia and others are likely to propel growth of the market.

Some Of Major Key Players In Digital Therapeutics Market:-

Propeller Health, CANARY HEALTH, Noom, 2Morrow, Livongo Health, Proteus Digital Health, WellDoc, Fitbit, Omada Health, MANGO HEALTH, And Others

Key developments in the Digital Therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as service launches, service approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players.

Strategic Insights:-

Product launch/update and partnerships were observed as the most adopted strategy in global digital therapeutics industry. Few of the product approvals and partnerships made by the players in the market are listed below:

2017: In November, Propeller Health and Express Scripts entered into a partnership to provide Propeller’s FDA-cleared digital solutions to Express Scripts to manage asthma or COPD.

2016: In November, Propeller Health received FDA approval for its Propeller platform for use with GSK’s Ellipta inhaler.

2018: In April, Canary Health entered into a partnership with NMRHCA to offer the Better Choices, Better Health (BCBH) digital therapeutics program in New Mexico.

2016: In June, Canary Health partnered with Medtronic to expand their diabetes care offerings with Canary Health's self-management suite for pre-diabetes, diabetes and related comorbidities.

Inquiry for More Discount Offers@ https://www.theinsightpartners.com/discount/TIPHC00002236/?op-sp

Rising prevalence of chronic diseases to boost market growth:-

Chronic diseases, including heart disease, stroke, diabetes, and obesity, are the leading causes of death in the world and account for most of the nation’s health care costs. According to report of CDC, in 2018, approximately more than 9% of the population has diabetes, which is the leading cause of kidney failure, lower-limb amputations in US. Moreover, the data also suggests that 1.5 million Americans are diagnosed with diabetes every year in the US. Similar trends for high presence of diabetes are prevalent around other geographies of the globe that include Asia Pacific, Europe, Middle East and Africa.

For instance, according to IDF Diabetes Atlas published by the International Diabetes Federation in 2017, south-east Asia is home to approximately one-fifth (19%) of the total diabetes population worldwide. According to the report of American College of Cardiology Foundation, in 2018, Coronary heart disease (CHD) was the leading cause of deaths attributable to cardiovascular disease (CVD) in the US, which is followed by stroke (16.8%), high BP (9.4%), heart failure (HF) (9.0%), and other CVDs (17.9%). By 2035, approximately 130 million adults in the US population are projected to have some form of CVD. Thus, increasing geriatric population and related chronic diseases are expected to propel the growth of global digital therapeutics market over the forecast years.

Rising Pressure on Healthcare Providers to Reduce Healthcare Costs:-

Digital therapeutics help in reducing the costs associated with chronic diseases, by helping an individual or an insurance provider to keep a track of one’s health status as well as track it with the help of digital means. As per American Diabetes Association, the estimated costs of diagnosed diabetes have risen to $327 billion in 2017, including $237 billion in direct medical costs and $90 billion in reduced productivity. This cost can be managed efficiently by including digital therapeutics that are offered by providers to help manage diabetes, can help patients get assistance with disease management and overcome the logistical challenges uncovered by the investigators.

Application Insights:-

The digital therapeutics market by application is segmented into diabetes, cardiovascular diseases, and central nervous system diseases, respiratory diseases, smoking cessation, musculoskeletal diseases and others. In 2017, the diabetes segment held a largest market share of 26.6% of the digital therapeutics, by application. This segment is also expected to dominate the market in 2025. The growth of the market is primarily attributed to the rising prevalence of diabetes cases across the globe and also the segment is expected to grow with the fastest growth rate of 22.0% during the forecast period, 2018 to 2025.

Distribution Channel Insights:-

On the basis of distribution channel, the digital therapeutics market is segmented into patients, providers, payers, and employers. In 2017, the patients segment is expected to dominate the market based on the distribution channel contributing a share of 39.2%. This is primarily attributed to growing prevalence for the need to self-monitor as well as manage one’s health status. However, providers segment is anticipated to grow at a fastest growth rate of 21.3% during the forecast period.

Highlights of the report:

• A complete backdrop analysis, which includes an assessment of the parent market

• Important changes in market dynamics

• Emerging niche segments and regional markets

• An objective assessment of the trajectory of the market

• Recommendations to companies for strengthening their foothold in the market

• Market segmentation up to the second or third level

• Historical, current, and projected size of the market from the standpoint of both value and volume

• Reporting and evaluation of recent industry developments

• Market shares and strategies of key players

Any Questions? Inquiry before Buying Visit @ https://www.theinsightpartners.com/inquiry/TIPHC00002236/?op-sp

Contact us:

The Insight partners,

Phone: +1-646-491-9876

Email: sales@theinsightpartners.com

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.

This release was published on openPR.